Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
GT Healthcare Capital Partners is a life science-focused private equity and venture capital firm founded in September 2015 by Alan Au. Although often associated with the United States, the firm is headquartered in Hong Kong and specializes in cross-border healthcare investments, particularly in China and Greater Asia. The firm is dedicated to supporting innovative companies that are developing technologies to improve healthcare delivery and patient outcomes.
As of now, GT Healthcare Capital Partners manages a fund size of $27 million and has made significant strides in the healthcare sector. The firm has a portfolio that includes notable companies such as Oxford Nanopore Technologies and Potrero Medical. GT Healthcare Capital Partners has established itself as a key player in the healthcare investment space, focusing on early-stage companies that are poised to make substantial impacts in healthcare.
GT Healthcare Capital Partners primarily invests in the healthcare sector, with a strong emphasis on medical devices, pharmaceuticals, and artificial intelligence applications in drug discovery. The firm targets early-stage companies, including those in pre-seed, seed, Series A, Series B, and growth equity stages. The typical check size ranges from $1 million to $5 million, depending on the specific needs of the portfolio companies.
The firm’s investment strategy is centered around technologies that enhance patient care and outcomes. GT Healthcare Capital Partners looks for companies that are developing innovative solutions to improve healthcare delivery. Their geographic focus includes the United States and Greater Asia, particularly China, where they leverage their expertise and connections to navigate regulatory landscapes and market entry challenges.
GT Healthcare Capital Partners has a diverse portfolio of companies making significant advancements in healthcare technology. Notable portfolio companies include:
Alan Au: Founder & Managing Partner. Alan Au has a background as a pharmaceutical executive and serves as a board member of NovaBridge Biosciences. He has extensive experience in the healthcare sector and leads the firm's investment strategy.
To pitch to GT Healthcare Capital Partners, founders should submit their proposals through the firm's website at gthcap.com. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. The firm prefers warm introductions but will consider direct submissions.
Response times can vary, but founders should expect to hear back within a few weeks. Clear and concise communication is essential to capture the firm's interest.
In recent months, GT Healthcare Capital Partners has been active in funding innovative healthcare companies. They led a $31 million Series A funding round for Moon Surgical and participated in a $75 million Series B funding round for ONI. The firm continues to support its portfolio companies in navigating the healthcare landscape and expanding their market reach.
What are GT Healthcare Capital Partners' investment criteria?
The firm primarily invests in early-stage healthcare companies, particularly in medical devices and pharmaceuticals. They focus on technologies that can significantly improve patient care and healthcare systems.
How can I apply or pitch to GT Healthcare Capital Partners?
Founders can pitch their ideas through the firm's website at gthcap.com. It is advisable to include a detailed business plan and information about the team and technology.
What makes GT Healthcare Capital Partners different from other investors?
GT Healthcare Capital Partners specializes in cross-border investments, particularly in Greater China, providing unique access to Asian markets for their portfolio companies.
What is the geographic scope of GT Healthcare Capital Partners?
The firm primarily focuses on the United States and Greater Asia, especially China, leveraging its expertise in navigating these markets.
What is the typical fund size and check size for investments?
GT Healthcare Capital Partners manages a fund size of $27 million, with typical check sizes ranging from $1 million to $5 million depending on the stage and needs of the company.
What kind of post-investment involvement does GT Healthcare Capital Partners have?
The firm actively supports its portfolio companies by providing strategic guidance, helping navigate regulatory landscapes, and expanding market reach, particularly in cross-border contexts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.